{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:52:47Z","timestamp":1791226367972,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"DOI":"10.1007\/s12328-026-02445-7","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:40:54Z","timestamp":1791178854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An unresectable cholangiolocarcinoma diagnosed by integrating biopsy-based histopathology and genomic findings with clinical and imaging data"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3441-647X","authenticated-orcid":false,"given":"Yukinari","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyo","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"2445_CR1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/1097-0142(195907\/08)12:4<753::AID-CNCR2820120420>3.0.CO;2-L","volume":"12","author":"PE Steiner","year":"1959","unstructured":"Steiner PE, Higginson J. Cholangiolocellular carcinomas of the liver. Cancer. 1959;12:753\u20139.","journal-title":"Cancer"},{"key":"2445_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/RCT.0b013e318195400c","volume":"33","author":"U Motosugi","year":"2009","unstructured":"Motosugi U, Ichikawa T, Nakajima H, et al. Cholangiolocellular carcinoma of the liver: Imaging findings. J Comput Assist Tomogr. 2009;33:682\u20138.","journal-title":"J Comput Assist Tomogr"},{"key":"2445_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00261-016-0944-z","volume":"42","author":"K Kozaka","year":"2017","unstructured":"Kozaka K, Matsui O, Kobayashi S, et al. Dynamic CT findings of cholangiolocellular carcinoma: correlation with angiography-assisted CT and histopathology. Abdom Radiol. 2017;42:861\u20139.","journal-title":"Abdom Radiol"},{"key":"2445_CR4","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1007\/s00330-017-4811-2","volume":"27","author":"H Haradome","year":"2017","unstructured":"Haradome H, Unno T, Morisaka H, et al. Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations. Eur Radiol. 2017;27:4461\u201371.","journal-title":"Eur Radiol"},{"key":"2445_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1533033820948141","volume":"19","author":"H Takamura","year":"2020","unstructured":"Takamura H, Gabata R, Obatake Y, et al. Clinical features and diagnostic imaging of cholangiolocellular carcinoma compared with other primary liver cancers: a surgical perspective. Technol Cancer Res Treat. 2020;19:1\u201317.","journal-title":"Technol Cancer Res Treat"},{"key":"2445_CR6","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/hep.22238","volume":"47","author":"M Komuta","year":"2008","unstructured":"Komuta M, Spee B, Vander Borght S, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 2008;47:1544\u201356.","journal-title":"Hepatology"},{"key":"2445_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.humpath.2017.01.016","volume":"64","author":"J Chen","year":"2017","unstructured":"Chen J, He J, Deng M, et al. Clinicopathological, radiologic, and molecular study of 23 combined hepatocellular-cholangiocarcinomas with stem cell features, cholangiolocellular type. Hum Pathol. 2017;64:118\u201327.","journal-title":"Hum Pathol"},{"key":"2445_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2017.01.010","volume":"66","author":"A Moeini","year":"2017","unstructured":"Moeini A, Sia D, Zhang Z, et al. Mixed hepatocellular cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity. J Hepatol. 2017;66:952\u201361.","journal-title":"J Hepatol"},{"key":"2445_CR9","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/s41379-019-0290-0","volume":"32","author":"D Balitzer","year":"2019","unstructured":"Balitzer D, Joseph NM, Ferrell L, et al. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma. Mod Pathol. 2019;32:1486\u201394.","journal-title":"Mod Pathol"},{"key":"2445_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/hepr.13428","volume":"50","author":"H Kusano","year":"2020","unstructured":"Kusano H, Naito Y, Mihara Y, et al. Distinctive clinicopathological features and KRAS and IDH1\/2 mutation status of cholangiolocellular carcinoma. Hepatol Res. 2020;50:84\u201391.","journal-title":"Hepatol Res"},{"key":"2445_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/his.14417","volume":"79","author":"HN Canh","year":"2021","unstructured":"Canh HN, Takahashi K, Yamamura M, et al. Diversity in cell differentiation, histology, phenotype and vasculature of mass-forming intrahepatic cholangiocarcinomas. Histopathology. 2021;79:731\u201350.","journal-title":"Histopathology"},{"key":"2445_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/path.6257","volume":"263","author":"K Makino","year":"2024","unstructured":"Makino K, Ishii T, Takeda H, et al. Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency. J Pathol. 2024;263:32\u201346.","journal-title":"J Pathol"},{"key":"2445_CR13","first-page":"254","volume-title":"WHO classification of tumors of the digestive system","author":"Y Nakamura","year":"2019","unstructured":"Nakamura Y, Klimstra D, Komuta M, Zen Y. Intrahepatic cholangiocarcinoma. In: WHO classification of tumors of the digestive system. 5 ed. Lyon: IARC; 2019. p. 254\u20139.","edition":"5 ed"},{"key":"2445_CR14","doi-asserted-by":"publisher","first-page":"59113","DOI":"10.18632\/oncotarget.19262","volume":"8","author":"T Nakagaki","year":"2017","unstructured":"Nakagaki T, Tamura M, Kobashi K, et al. Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing. Oncotarget. 2017;8:59113\u201322.","journal-title":"Oncotarget"},{"key":"2445_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Macarulla T, Javle MM, et al. Ivosidenib in IDH-1 mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicenter, randomized, double-blind, placebo-controlled, phase III study. Lancet Oncol. 2020;21:796\u2013807.","journal-title":"Lancet Oncol"},{"issue":"7274","key":"2445_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739\u201344.","journal-title":"Nature"},{"key":"2445_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1021\/acsmedchemlett.7b00421","volume":"9","author":"J Popovici-Muller","year":"2018","unstructured":"Popovici-Muller J, Lemieux RM, Artin E, et al. Discovery of AG-120 (ivosidenib): a first-in-class mutant IDH1 inhibitor for the treatment of IDH1 mutant cancers. ACS Med Chem Lett. 2018;9:300\u20135.","journal-title":"ACS Med Chem Lett"},{"key":"2445_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","volume":"17","author":"DR Borger","year":"2012","unstructured":"Borger DR, Tanabe KK, Fan KC, et al. Frequent mutation of isocitrate dehydrogenase (IDH) 1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist. 2012;17:72\u20139.","journal-title":"Oncologist"},{"key":"2445_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Arai Y, Totoki Y, et al. Genomic spectra of biliary tract cancer. Nat Genet. 2015;47:1003\u201310.","journal-title":"Nat Genet"},{"key":"2445_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.humpath.2019.05.002","volume":"91","author":"T Wang","year":"2019","unstructured":"Wang T, Drill E, Vakiani E, et al. Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma. Hum Pathol. 2019;91:19\u201325.","journal-title":"Hum Pathol"},{"key":"2445_CR21","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/hep.32424","volume":"75","author":"MJ Wu","year":"2022","unstructured":"Wu MJ, Shi L, Merritt J, et al. Biology of IDH mutant cholangiocarcinoma. Hepatology. 2022;75:1322\u201337.","journal-title":"Hepatology"},{"key":"2445_CR22","doi-asserted-by":"publisher","first-page":"S451","DOI":"10.1245\/s10434-014-3582-0","volume":"21","author":"S Ariizumi","year":"2014","unstructured":"Ariizumi S, Kotera Y, Katagiri S, et al. Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy. Ann Surg Oncol. 2014;21:S451\u20138.","journal-title":"Ann Surg Oncol"},{"key":"2445_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3892\/ol.2024.14346","volume":"27","author":"H Sugita","year":"2024","unstructured":"Sugita H, Nakamura S, Gabata R, et al. Clinicopathological features of cholangiolocarcinoma and impact of tumor heterogeneity on prognosis: a single institution retrospective study. Oncol Lett. 2024;27:213.","journal-title":"Oncol Lett"},{"key":"2445_CR24","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.hpb.2019.10.009","volume":"22","author":"T Chung","year":"2020","unstructured":"Chung T, Rhee H, Nahm JH, et al. Clinicopathological characteristics of intrahepatic cholangiocarcinoma according to gross morphologic type: cholangiocellular differentiation traits and inflammation- and proliferation-phenotypes. HPB. 2020;22:864\u201373.","journal-title":"HPB"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02445-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02445-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:02:51Z","timestamp":1791223371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02445-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":24,"alternative-id":["2445"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02445-7","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","label":"Human rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient\u2019s family for the publication of her case details.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}